logo
  

AZN : Imfinzi Plus Novel Immunotherapies Improve Clinical Outcomes For Patients With Lung Cancer

AstraZeneca PLC (AZN,AZN.L) said Friday that results from the large, randomized COAST Phase II trial showed oleclumab, an anti-CD73 monoclonal antibody, or monalizumab, an anti-NKG2A monoclonal antibody, in combination with Imfinzi or durvalumab improved progression-free survival or PFS and objective response rate or ORR compared to Imfinzi alone in patients with unresectable, Stage III non-small cell lung cancer or NSCLC who had not progressed after concurrent chemoradiation therapy or CRT.

After a median follow-up of 11.5 months, the results of an interim analysis showed IMFINZI in combination with oleclumab reduced the risk of disease progression or death by 56%, and in combination with monalizumab by 35%, when compared to Imfinzi alone in Stage III NSCLC patients following CRT.

The 10-month PFS rate was 64.8% for the durvalumab plus oleclumab combination and 72.7% for durvalumab plus monalizumab, versus 39.2% with durvalumab alone.

The results also showed an increase in the primary endpoint of confirmed ORR for IMFINZI plus oleclumab over IMFINZI alone and for IMFINZI plus monalizumab over IMFINZI alone.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Merck & Co., Inc., known as MSD outside the U.S. and Canada, has recalled one lot of intravenous antibiotic Cubicin (daptomycin for injection) 500 mg for the potential presence of particulate matter identified as glass particles, the U.S. Food and Drug Administration or FDA said in a statement. The National Restaurant Association or NRA shot out a letter to the U.S. Conference of Mayors suggesting that expanded outdoor dining is the need of the hour for the restaurant industry to sustain the winter. The NRA also warned that thousands of restaurants without this facility could close down very soon. The U.S. Food and Drug Administration is investigating a multistate outbreak of Salmonella Oranienburg infections linked to whole, fresh onions. The outbreak has resulted in 652 illnesses in consumers across the U.S. to date. The traceback investigation has identified Hailey, Idaho -based ProSource Inc., also known as ProSource Produce, LLC, as a source.
Follow RTT